109 related articles for article (PubMed ID: 21704933)
1. The evolving role of hemodilution in treatment of cerebral vasospasm: a historical perspective.
Chittiboina P; Conrad S; McCarthy P; Nanda A; Guthikonda B
World Neurosurg; 2011; 75(5-6):660-4. PubMed ID: 21704933
[TBL] [Abstract][Full Text] [Related]
2. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
[TBL] [Abstract][Full Text] [Related]
3. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.
Ekelund A; Reinstrup P; Ryding E; Andersson AM; Molund T; Kristiansson KA; Romner B; Brandt L; Säveland H
Acta Neurochir (Wien); 2002 Jul; 144(7):703-12; discussion 712-3. PubMed ID: 12181704
[TBL] [Abstract][Full Text] [Related]
4. New concepts regarding cerebral vasospasm: glial-centric mechanisms.
Mutch WA
Can J Anaesth; 2010 May; 57(5):479-89. PubMed ID: 20131107
[TBL] [Abstract][Full Text] [Related]
5. Medically induced hypertension, hypervolaemia and haemodilution for the treatment and prophylaxis of vasospasm following aneurysmal subarachnoid haemorrhage: systematic review.
Loan JJM; Wiggins AN; Brennan PM
Br J Neurosurg; 2018 Apr; 32(2):157-164. PubMed ID: 29338431
[TBL] [Abstract][Full Text] [Related]
6. Detecting and treating microvascular ischemia after subarachnoid hemorrhage.
Sakowitz OW; Unterberg AW
Curr Opin Crit Care; 2006 Apr; 12(2):103-11. PubMed ID: 16543784
[TBL] [Abstract][Full Text] [Related]
7. Which H is the most important in triple-H therapy for cerebral vasospasm?
Treggiari MM; Deem S
Curr Opin Crit Care; 2009 Apr; 15(2):83-6. PubMed ID: 19276798
[TBL] [Abstract][Full Text] [Related]
8. The present role of "triple-H" therapy in the management of cerebral vasospasm.
Findlay JM
World Neurosurg; 2010; 74(2-3):244-6. PubMed ID: 21492545
[No Abstract] [Full Text] [Related]
9. Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage.
Meyer R; Deem S; Yanez ND; Souter M; Lam A; Treggiari MM
Neurocrit Care; 2011 Feb; 14(1):24-36. PubMed ID: 20838932
[TBL] [Abstract][Full Text] [Related]
10. "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
Lee KH; Lukovits T; Friedman JA
Neurocrit Care; 2006; 4(1):68-76. PubMed ID: 16498198
[TBL] [Abstract][Full Text] [Related]
11. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage.
Raabe A; Beck J; Keller M; Vatter H; Zimmermann M; Seifert V
J Neurosurg; 2005 Dec; 103(6):974-81. PubMed ID: 16381183
[TBL] [Abstract][Full Text] [Related]
12. Computational modeling of HHH therapy and impact of blood pressure and hematocrit.
Robinson JS; Walid MS; Hyun S; O'Connell R; Menard C; Bohleber B
World Neurosurg; 2010; 74(2-3):294-6. PubMed ID: 21492563
[TBL] [Abstract][Full Text] [Related]
13. Triple H therapy after aneurysmal subarachnoid hemorrhage. A review.
Romner B; Reinstrup P
Acta Neurochir Suppl; 2001; 77():237-41. PubMed ID: 11563296
[No Abstract] [Full Text] [Related]
14. Role of transcranial Doppler in optimizing treatment of cerebral vasospasm in subarachnoid hemorrhage.
Darwish RS; Ahn E; Amiridze NS
J Intensive Care Med; 2008; 23(4):263-7. PubMed ID: 18480082
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage.
Treggiari MM; Walder B; Suter PM; Romand JA
J Neurosurg; 2003 May; 98(5):978-84. PubMed ID: 12744357
[TBL] [Abstract][Full Text] [Related]
16. Monitoring intravascular volumes to direct hypertensive, hypervolemic therapy in a patient with vasospasm.
Segal E; Greenlee JD; Hata SJ; Perel A
J Neurosurg Anesthesiol; 2004 Oct; 16(4):296-8. PubMed ID: 15557835
[TBL] [Abstract][Full Text] [Related]
17. Cerebral vasospasm after subarachnoid hemorrhage: hypertensive hypervolemic hemodilution (triple-H) therapy according to new systemic hemodynamic parameters.
Krayenbühl N; Hegner T; Yonekawa Y; Keller E
Acta Neurochir Suppl; 2001; 77():247-50. PubMed ID: 11563298
[No Abstract] [Full Text] [Related]
18. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 98:978-984, May, 2003.
Egge A; Waterloo K; Sjøholm H; Solberg T; Ingebrigtsen T; Romner B
J Neurosurg; 2004 Feb; 100(2):359-60; author reply 360. PubMed ID: 15086250
[No Abstract] [Full Text] [Related]
19. Prophylactic hypervolemia without calcium channel blockers in early aneurysm surgery.
Origitano TC; Reichman OH; Anderson DE
Neurosurgery; 1992 Oct; 31(4):804-6. PubMed ID: 1407476
[No Abstract] [Full Text] [Related]
20. [Systemic treatments of the vasospasm].
Tavernier B; Decamps F; Vega E; Poidevin P; Verdin M; Riegel B
Ann Fr Anesth Reanim; 2007 Nov; 26(11):980-4. PubMed ID: 17933488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
